Cargando…

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease

Parkinson’s disease (PD) is characterized pathologically by intraneuronal inclusions called Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-synuclein is toxic. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Winslow, Ashley R., Chen, Chien-Wen, Corrochano, Silvia, Acevedo-Arozena, Abraham, Gordon, David E., Peden, Andrew A., Lichtenberg, Maike, Menzies, Fiona M., Ravikumar, Brinda, Imarisio, Sara, Brown, Steve, O’Kane, Cahir J., Rubinsztein, David C.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101586/
https://www.ncbi.nlm.nih.gov/pubmed/20855506
http://dx.doi.org/10.1083/jcb.201003122
Descripción
Sumario:Parkinson’s disease (PD) is characterized pathologically by intraneuronal inclusions called Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-synuclein is toxic. In this study, we demonstrate that α-synuclein overexpression impairs macroautophagy in mammalian cells and in transgenic mice. Our data show that α-synuclein compromises autophagy via Rab1a inhibition and Rab1a overexpression rescues the autophagy defect caused by α-synuclein. Inhibition of autophagy by α-synuclein overexpression or Rab1a knockdown causes mislocalization of the autophagy protein, Atg9, and decreases omegasome formation. Rab1a, α-synuclein, and Atg9 all regulate formation of the omegasome, which marks autophagosome precursors.